The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTI.L Regulatory News (CTI)

  • There is currently no data for CTI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

9 Apr 2015 07:00

RNS Number : 7007J
Cathay International Holdings Ld
09 April 2015
 

Cathay International Holdings Limited

("Cathay" or the "Company")

Transaction in Own Shares

 

Hong Kong, 9 April 2015 - Cathay International Holdings Ltd. (LSE: CTI.L), an investment holding company and a leading operator and investor in the growing healthcare sector in the People's Republic of China, today announces that on 8 April 2015 it purchased 4,644 common shares at an average price of 23 pence (this also being the highest and lowest price paid per common share).

 

All the purchased shares will be held as treasury shares. Following the purchase of these shares, the Company holds 4,644 of its common shares in treasury and has 371,952,361 common shares in issue (excluding treasury shares).

 

For further enquiries, please contact:

 

Cathay International Holdings Limited

Eric Siu (Finance Director)

Patrick Sung (Director and Controller)

 

Tel: +852 2828 9289

 

Consilium Strategic Communications

Mary-Jane Elliott / Amber Bielecka / Matthew Neal / Lindsey Neville

 

Tel: +44 (0)203 709 5708

 

 

About Cathay

Cathay International Holdings Limited (LSE: CTI.L) is a main market listed investment holding company and a leading operator and investor in the growing healthcare sector in the People's Republic of China ("PRC"). The Company and its subsidiaries (collectively the "Group") aim to leverage on growth opportunities in the strong and growing domestic demand for high quality healthcare products in China and build its portfolio companies into market sector leaders with competitive edge. Cathay has already demonstrated a strong track record of identifying high-growth potential investment opportunities in this area including: Lansen, China's leading specialty pharmaceutical company focused on rheumatology and dermatology; Haizi, a company engaged in the manufacture, marketing and sales of inositol and its by-product, di-calcium phosphate; Yangling, a company engaged in production and sales of plant extracts for use as key active ingredients in healthcare products; and Botai, a company engaged in collagen products.

The Group employs approximately 2,000 people across the PRC, including over 30 specialist corporate and business development staff based at the holding company's offices in Hong Kong and Shenzhen. Cathay also has a hotel investment.

For more information please visit the Company's website: www.cathay-intl.com.hk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
POSPKCDPPBKKPQK
Date   Source Headline
1st Apr 20118:59 amRNSGrant of Share Options
24th Mar 20119:02 amRNSAnnual Report and Accounts
18th Mar 20119:09 amRNSGrant of share options
16th Mar 20117:00 amRNSAnnual Results for the Year Ended 31 December 2010
10th Mar 20119:55 amRNSNotice of Results
9th Mar 20117:00 amRNSAppointment of Adviser
29th Nov 20107:30 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
19th Nov 20107:27 amRNSInterim Management Statement
16th Nov 20107:00 amRNSZhejiang Starry Pharmaceutical Co., Ltd.
26th Aug 20105:04 pmRNSINTERIM RESULTS 2010
4th Jun 20107:00 amRNSResults of AGM and change of Director's role
1st Jun 20107:06 amRNSLansen Pharmaceutical Holdings - Update
19th May 20103:32 pmRNSInterim Management Statement
12th May 201010:37 amRNSAnnual Information Update
6th May 20107:32 amRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:25 pmRNSLansen Pharmaceutical Holdings Company Limited
27th Apr 20104:22 pmRNSPRELIMINARY RESULTS
19th Apr 20101:41 pmRNSResult of Special General Meeting
16th Apr 201012:38 pmRNSSpecial General Meeting on 19 April 2010
6th Apr 20105:18 pmRNSPublication of Circular
1st Apr 20101:09 pmRNSLansen Pharmaceutical Holdings Company
23rd Mar 20109:00 amRNSAdditional Listing
26th Feb 20109:07 amRNSAdditional Listing
12th Feb 20106:06 pmRNSUpdate on further investment in Xian Haotian Group
26th Jan 20105:18 pmRNSAnnual Information Update
21st Jan 20105:56 pmRNSAppointment of Directors and Issue of Equity
7th Dec 20099:11 amRNSTotal Voting Rights and Share Capital
4th Dec 200911:16 amRNSResult of SGM
4th Dec 20097:06 amRNSResult of Placing Open Offer
19th Nov 200911:03 amRNSInterim Management Statement
18th Nov 20095:24 pmRNSPublication of Prospectus
18th Nov 20097:00 amRNSPlacing and Open Offer
26th Aug 20092:00 pmRNSInterim Results 2009
22nd Jul 20094:40 pmRNSSecond Price Monitoring Extn
22nd Jul 20094:35 pmRNSPrice Monitoring Extension
26th May 200911:08 amRNSHolding(s) in Company
1st May 20099:30 amRNSDirectorate Change
1st May 20099:28 amRNSResult of AGM
1st May 20097:00 amRNSDIRECTORATE CHANGE
14th Apr 20091:45 pmRNSInterim Management Statement
6th Apr 20095:30 pmRNSPRELIMINARY RESULTS
23rd Jan 200912:27 pmRNSAnnual Information Update
19th Nov 200811:04 amRNSInterim Management Statement
12th Sep 20082:09 pmRNSFurther Update on Xian Haotian
29th Aug 20084:00 pmRNSInterim Results
30th May 20083:18 pmRNSResult of AGM and SGM
19th May 20087:30 amRNSInterim Management Statement
29th Apr 20082:47 pmRNSFinal Results
29th Apr 20088:39 amRNSXian Haotian Circular
28th Apr 20082:09 pmRNSCirc re Xian Haotian

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.